Literature DB >> 24120394

MiR-375, a microRNA related to diabetes.

Xueling Li1.   

Abstract

MiR-375 is an important small non-coding RNA that is specifically expressed in islet cells of the pancreas. miR-375 is required for normal pancreatic genesis and influences not only β-cell mass but also α-cell mass. miR-375 is also important to glucose-regulated insulin secretion through the regulation of the expression of Mtpn and Pdk1 genes. When human embryonic stem cells (hESCs) differentiate into endodermal lineages, miR-375 is highly expressed in the definitive endoderm, which suggests that miR-375 may have a distinct role in early development. miR-375 plays an important role in the complex regulatory network of pancreatic development, which could be regulated by pancreatic genes, such as NeuroD1, Ngn3, Pdx1 and Hnf6; additionally, miR-375 regulates genes related to pancreas development, cell growth and proliferation and insulin secretion genes to exert its function. Because of the special role of miR-375, it may be a potential target to treat diabetes. Antagonising miR-375 may enhance the effects of exendin-4 in patients, and controlling the expression of miR-375 could assist mature hESCs-derived β-cells.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3′ UTRs; AIFM1; CADM1; CAV1; CLQBP; Diabetes; EEFLE1; ELAV (embryonic lethal, abnormal vision, drosophila)-like 4; EPAC2; GEF II; GLP-1; HNF1β; HUD; ID3; INSM1; Insulin; MTPN; NGN3; PAX6; PDK1; PDX1; PKA; Pancreas; RAS, dexamethasone-induced 1; RASD1; RGS16; SMARCA2; SOX; SRY (sex determining region Y)-box; SWI/SNF related matrix associated, actin dependent regulator of chromatin, subfamily A, member 2; WHO; World Health Organization; apoptosis-inducing factor, mitochondrion-associated 1; bHLH; basic helix–loop–helix; cAMP; caveolin 1; cell adhesion molecule 1; complement component 1, Q subcomponent binding protein; cyclic adenosine monophosphate; eukaryotic translation elongation factor 1 epsilon 1; exchange protein activated by cyclic AMP 2; glucagon-like peptide-1; guanine nucleotide exchange factor II; hESCs; hepatocyte nuclear factor 1beta; human embryonic stem cells; iPSCs; induced pluripotent stem cells; inhibitor of DNA binding 3; insulinoma-associated protein 1; miR-375; miRNAs; microRNA; myotrophin; neurogenin 3; paired box gene 6; pancreatic and duodenal homeobox 1; protein kinase A; pyruvate dehydrogenase kinase, isozyme 1; regulator of G-protein signaling 16; the 3′ untranslated regions; β-Cells

Mesh:

Substances:

Year:  2013        PMID: 24120394     DOI: 10.1016/j.gene.2013.09.105

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  31 in total

1.  The Biochemical Cascades of the Human Pancreatic β-Cells: The Role of MicroRNAs.

Authors:  Joseph W Kim; John Z Luo; Luguang Luo
Journal:  J Bioanal Biomed       Date:  2015-12-11

Review 2.  Why the hype - What are microRNAs and why do they provide unique investigative, diagnostic, and therapeutic opportunities in veterinary medicine?

Authors:  Joshua Antunes; Olivia Lee; Amir Hamed Alizadeh; Jonathan LaMarre; Thomas Gadegaard Koch
Journal:  Can Vet J       Date:  2020-08       Impact factor: 1.008

Review 3.  Beyond the Protein-Coding Sequence: Noncoding RNAs in the Pathogenesis of Type 2 Diabetes.

Authors:  Johanna K DiStefano
Journal:  Rev Diabet Stud       Date:  2016-01-28

4.  MicroRNA-214 suppresses gluconeogenesis by targeting activating transcriptional factor 4.

Authors:  Kai Li; Jin Zhang; Junjie Yu; Bin Liu; Yajie Guo; Jiali Deng; Shanghai Chen; Chunxia Wang; Feifan Guo
Journal:  J Biol Chem       Date:  2015-02-05       Impact factor: 5.157

Review 5.  Circulating miRNAs as biomarkers for endocrine disorders.

Authors:  H Butz; N Kinga; K Racz; A Patocs
Journal:  J Endocrinol Invest       Date:  2015-05-28       Impact factor: 4.256

6.  MicroRNA-375 repression of Kruppel-like factor 5 improves angiogenesis in diabetic critical limb ischemia.

Authors:  Michael G McCoy; Anurag Jamaiyar; Grasiele Sausen; Henry S Cheng; Daniel Pérez-Cremades; Rulin Zhuang; Jingshu Chen; Philip P Goodney; Mark A Creager; Marc S Sabatine; Marc P Bonaca; Mark W Feinberg
Journal:  Angiogenesis       Date:  2022-09-08       Impact factor: 10.658

7.  Effect of Anti-Osteoporotic Treatments on Circulating and Bone MicroRNA Patterns in Osteopenic ZDF Rats.

Authors:  David Carro Vázquez; Lejla Emini; Martina Rauner; Christine Hofbauer; Johannes Grillari; Andreas B Diendorfer; Richard Eastell; Lorenz C Hofbauer; Matthias Hackl
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

Review 8.  Role of miRNAs in the pathogenesis of T2DM, insulin secretion, insulin resistance, and β cell dysfunction: the story so far.

Authors:  Prabhsimran Kaur; Sushil Kotru; Sandeep Singh; Bidwan Sekhar Behera; Anjana Munshi
Journal:  J Physiol Biochem       Date:  2020-08-04       Impact factor: 4.158

9.  miR-375 controls porcine pancreatic stem cell fate by targeting 3-phosphoinositide-dependent protein kinase-1 (Pdk1).

Authors:  Shuxian Hu; Mingzhi Zhang; Fen Sun; Lipeng Ren; Xin He; Jinlian Hua; Sha Peng
Journal:  Cell Prolif       Date:  2016-06       Impact factor: 6.831

Review 10.  Adipocyte, Immune Cells, and miRNA Crosstalk: A Novel Regulator of Metabolic Dysfunction and Obesity.

Authors:  Sonia Kiran; Vijay Kumar; Santosh Kumar; Robert L Price; Udai P Singh
Journal:  Cells       Date:  2021-04-24       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.